Workflow
阅文集团(00772.HK):业绩基本符合预期 IP衍生品业务加速发展
Ge Long Hui·2025-08-15 03:49

Core Viewpoint - The company's 1H25 performance shows a decline in revenue and Non-IFRS net profit, but the results are in line with expectations, with a notable growth in other business segments excluding a specific impact from New丽传媒 [1][2]. Financial Performance - In 1H25, the company achieved revenue of 3.191 billion yuan, a year-on-year decrease of 23.9% - Non-IFRS net profit was 508 million yuan, down 27.7%, aligning with the company's forecast of 486 million yuan and Bloomberg's estimate of 484 million yuan [1] - Excluding the impact of New丽传媒, other business segments saw a 35.7% year-on-year growth in Non-IFRS net profit [1] Business Segments - Online business revenue showed a slight increase, with 1H25 online business revenue at 1.985 billion yuan, up 2.3% - Self-owned platform product revenue grew by 3.1%, while Tencent channel revenue fell by 25.6% due to a significant drop in MAU, attributed to a strategic shift towards paid reading products [1] - IP operation revenue in 1H25 was 1.205 billion yuan, down 46.4%, primarily due to no new series from New丽传媒 in the first half of the year [1][2] - The GMV for IP derivative products reached 480 million yuan, nearing the total of 500 million yuan for the previous year [1] Profitability and Cost Management - The company's gross margin in 1H25 was 50.5%, reflecting a year-on-year increase of 0.5 percentage points - The reduction in sales expenses was due to fewer film projects, leading to decreased promotional and advertising costs [2] - Management expenses also saw a slight year-on-year decline, indicating a more restrained approach [2] Future Outlook - The company has a rich reserve of series from New丽传媒, with several projects scheduled for release in 2025, including "扫毒风暴" and others [2] - The short drama business is set to expand, with over 2,000 web novel IPs being utilized to create high-quality short dramas [3] - The company plans to enhance its IP derivative product offerings, with a significant increase in the speed of new product launches [3] Valuation and Estimates - The company maintains its Non-IFRS net profit forecasts for 2025 and 2026 - Current price corresponds to 21.2x and 18.4x Non-IFRS P/E for 2025 and 2026, respectively - The target price is set at 43.5 HKD, indicating a potential upside of 39.4% based on 30x and 26x Non-IFRS P/E for 2025 and 2026 [3]